Please don't hesitate to contact us if you have any questions or other inquiries.

The 6th annual AFDD Summit focusing on antifibrotic drug development

Nordic Bioscience looks forward to participating in the 6th Annual Antifibrotic Drug Development Summit (AFDD).

"Returning for the 6th year, the Antifibrotic Drug Development Summit (AFDD) will host the transferrable insights you need from professionals working in lung fibrosiskidney fibrosisliver fibrosis, and many more, at one place at one time, so you can advance the progress of your antifibrotic therapies.

From delving into incorporating repair and regeneration into your antifibrotic to exploring cellular mechanisms to identify a common fibrotic pathway and bridging the translational gap to prove early therapeutic effectiveness; this unique cross-organ, cross-disease, cross-discipline discussion forum is here to transform your fibrosis research." (6th Annual Antifibrotic Drug Development Summit)

Given our experience in fibrotic disease and helping pharmaceutical companies develop agents for fibrosis, we hope to reconnect with current and future partners. Our tissue turnover biomarkers are an excellent addition to any clinical trial targeting fibrotic disease, whether it is the lung, liver, kidney, heart, or other organ affected by fibrotic tissue.

Do not hesitate to contact us to discuss how we can work together!

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.